Dystonia and tremor following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxinKLAWANS, H. L.Movement disorders. 1987, Vol 2, Num 4, pp 255-261, issn 0885-3185Article

Recurrence of childhood multiple tic in late adult lifeKLAWANS, H. L; BARR, A.Archives of neurology (Chicago). 1985, Vol 42, Num 11, pp 1079-1080, issn 0003-9942Article

Dystonia-Parkinson syndrome: differential effects of Levodopa and dopamine agonistsKLAWANS, H. L; PALEOLOGOS, N.Clinical neuropharmacology. 1986, Vol 9, Num 3, pp 298-302, issn 0362-5664Article

Myoclonus and ParkinsonismKLAWANS, H. L; TANNER, C. M; MCDERMOTT, J et al.Clinical neuropharmacology. 1986, Vol 9, Num 2, pp 202-205, issn 0362-5664Article

Levodopa during pregnancyCOOK, D. G; KLAWANS, H. L.Clinical neuropharmacology. 1985, Vol 8, Num 1, pp 93-95, issn 0362-5664Article

The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced increases in locomotor acitivityFEIGENBAUM, J. J; YANAI, J; KLAWANS, H. L et al.Journal of neural transmission. 1983, Vol 57, Num 1-2, pp 27-37, issn 0300-9564Article

Convulsive disorders : mechanisms of epilepsy and anticonvulsant actionBLECK, T. P; KLAWANS, H. L.Clinical neuropharmacology. 1990, Vol 13, Num 2, pp 121-128, issn 0362-5664, 8 p.Article

Neurologic emergenciesBLECK, T. P; KLAWANS, H. L.The Medical clinics of North America. 1986, Vol 70, Num 5, pp 1167-1184, issn 0025-7125Article

Metrizamide and its neurologic complicationsBUCHMAN, A. S; KLAWANS, H. L; RUSSELL, E. J et al.Clinical neuropharmacology. 1987, Vol 10, Num 1, pp 1-25, issn 0362-5664Article

The effect of bilateral kainic acid-induced lateral habenula lesions on dopamine-mediated behaviorsCARVEY, P. M; LI CHIUNG KAO; KLAWANS, H. L et al.Brain research. 1987, Vol 409, Num 1, pp 193-196, issn 0006-8993Article

Hemiparkinsonism with hemiatrophyBUCHMAN, A. S; GOETZ, C. G; KLAWANS, H. L et al.Neurology. 1988, Vol 38, Num 4, pp 527-530, issn 0028-3878Article

Fluphenazine and multifocal tic disordersGOETZ, C. G; TANNER, C. M; KLAWANS, H. L et al.Archives of neurology (Chicago). 1984, Vol 41, Num 3, pp 271-272, issn 0003-9942Article

Bupropion in Parkinsońs diseaseGOETZ, C. G; TANNER, C. M; KLAWANS, H. L et al.Neurology. 1984, Vol 34, Num 8, pp 1092-1094, issn 0028-3878Article

Dopamine distribution and behavioral alterations resulting from dopamine infusion into the brain of the lesioned ratKROIN, J. S; LI CHIUNG KAO; TIE JIN ZHANG et al.Journal of neurosurgery. 1991, Vol 74, Num 1, pp 105-111, issn 0022-3085, 7 p.Article

Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum culturesCARVEY, P. M; PTAK, L. R; LO, E. S et al.Experimental neurology (Print). 1991, Vol 114, Num 1, pp 28-34, issn 0014-4886Article

Dopaminergic agonists in the treatment of Parkinson's disease. DiscussionGOETZ, C. G; KLAWANS, H. L; OLANOW, C. W et al.Neurology. 1990, Vol 40, Num 10, pp 50-57, issn 0028-3878, 8 p., Suppl. 3Article

Oxidation reactions in Parkinson's disease. DiscussionOLANOW, C. W; KLAWANS, H. L; KOLLER, W. C et al.Neurology. 1990, Vol 40, Num 10, pp 32-39, issn 0028-3878, 8 p., Suppl. 3Article

The genetics of Parkinson's disease : a reconsideration. DiscussionGOLBE, L. I; OLANOW, C. W; TANNER, C. M et al.Neurology. 1990, Vol 40, Num 10, pp 7-16, issn 0028-3878, 10 p., Suppl. 3Article

Effects of dopamine antagonists and apomorphine on regional energy metabolism in rat CNRCARVEY, P. M; BRAUN, A. R; LI-CHIUNG KAO et al.Clinical neuropharmacology. 1987, Vol 10, Num 3, pp 247-260, issn 0362-5664Article

Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic culturesCARVEY, P. M; PTAK, L. R; NATH, S. T et al.Experimental neurology (Print). 1993, Vol 120, Num 1, pp 149-152, issn 0014-4886Article

Blinded evaluation confirms long-term asymmetric effect of unilateral thalamotomyor subthalamotomy on tremor in Parkinson's diseaseDIEDERICHN; GOETZ, C. G; STEBBINS, G. T et al.Neurology. 1992, Vol 42, Num 7, pp 1311-1314, issn 0028-3878Article

Amantadine and motor fluctuations in chronic Parkinson's diseaseSHANNON, K. M; GOETZ, C. G; CARROLL, V. S et al.Clinical neuropharmacology. 1987, Vol 10, Num 6, pp 522-526, issn 0362-5664Article

Memory failure in Huntington's diseaseWILSON, R. S; COMO, P. G; GARRON, D. C et al.Journal of clinical and experimental neuropsychology. 1987, Vol 9, Num 2, pp 147-154, issn 0168-8634Article

Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in acontreatment paradigmCARVEY, P. M; NATH, S. T; KAO, L. C et al.European journal of pharmacology. 1990, Vol 184, Num 1, pp 43-53, issn 0014-2999, 11 p.Article

Agonist substitution in advanced Parkinson's diseaseGOETZ, C. G; SHANNON, K. M; TANNER, C. M et al.Neurology. 1989, Vol 39, Num 8, pp 1121-1122, issn 0028-3878Article